SUNTO. -La pelle è preposta a prevenire l'assorbimento di sostanze esogene. Questa funzione è esercitata dallo strato più superficiale dell'epidermide, lo strato corneo, costituito da circa 15-20 strati di corneociti parzialmente sovrapposti e supportati da un'impalcatura di cheratina. Gli spazi extracellulari sono riempiti con una matrice lipidica molto densa organizzata in lamelle periodiche. Gli spazi interlamellari sono invece costituiti da una matrice lipidica più fluida. Infine, dove i corneociti non sono perfettamente sovrapposti si creano dei pori a maggior contenuto di acqua. Questa complessa organizzazione permette la diffusione passiva solo di piccole molecole con peculiari proprietà chimico-fisiche. In tutti gli altri casi in cui sia auspicabile la veicolazione transdermica è necessario ricorrere all'impiego di tecniche che alterino in modo reversibile la funzionalità dello strato corneo come i promotori chimici dell'assorbimento, la ionoforesi o la sonoforesi. Nell'era delle nanotecnologie, un intenso sforzo è stato dedicato alla ricerca di nanovettori in grado di eludere le difese della pelle (nanoparticelle polimeriche, metalliche o solido-lipidiche, micro e nanoemulsioni, vescicole lipidiche). I risultati sono tuttora contrastanti e vi è nella comunità scientifica scetticismo sui reali vantaggi di questi sistemi rispetto agli altri approcci più tradizionali. Infatti, anche considerando lo strato corneo come una membrana nanoporosa con aperture di circa 20-40 nm, le dimensioni della maggior parte dei nanovettori sono tali da non consentirne teoricamente la diffusione. Tuttavia, nonostante queste criticità sul mercato si trovano alcuni medicinali costituiti da vescicole lipidiche "ultradeformabili". Partendo dall'analisi critica delle informazioni reperibili sui possibili meccanismi di penetrazione delle diverse tipologie di nanovettori si cercherà di evidenziare luci ed ombre della somministrazione di questi sistemi sulla cute. *** ABSTRACT. -The skin is the most important barrier of human body to prevent the absorption of exogenous substances. Its ability to limit the absorption of exogenous substances is exercised by the most superficial layer of the epidermis, the stratum corneum, which (*) Dipartimento di Scienze Farmaceutiche, Università degli Studi di Milano, Italia. E-mail: francesco.cilurzo@unimi.it consists of about 15-20 layers of corneocytes supported by keratin fibres. The extracellular spaces are filled with a very dense lipid matrix organized in periodic lamellae, whereas the interlamellar spaces are constituted by a more fluid lipid matrix. In addition, where the corneocytes are not perfectly overlapped, pores with a higher water content are created. This complex organization allows only the passive diffusion of small molecules with peculiar chemical-physical properties. In all the other cases, it is necessary to improve the transdermal absorption of drugs using techniques able to alter reversibly the functionality of the stratum corneum, such as chemical skin penetration enhancers, iontophoresis or sonophoresis. In the era of nanotechnology, an intense effort has been made to design nanocarriers able to permeate the skin (e.g., polymeric nanoparticles, metal or solid-lipid, micro-and nanoemulsions, lipid vesicles). Nevertheless, the results are contradictory and there is scepticism in the scientific community about the real benefits of these systems compared to other traditional approaches. In fact, assuming the stratum corneum as a nanoporous membrane with openings of about 20-40 nm, the size of most of the nanocarriers is too big for permitting theoretically the skin penetration and diffusion. However, despite this consideration, on the market there are some medicinal products consisting of lipid vesicles. Starting from the critical analysis of the published information on possible permeation mechanisms of different types of nanocarriers, this review outlines lights and shadows on the (trans-)dermal administration of these drug delivery systems.
INTRODUCTION
The (trans)dermal administration of drugs may be advantageously exploited to overcome the limits related to the poor oral bioavailability of many compounds and to minimize the side effects associated to parenteral route. Moreover, it allows to reach both a local or a systemic effect. Nevertheless, the skin structure evolved to prevent the contact of the body with exogenous molecules thanks to the excellent barrier properties of the stratum corneum, which is the outermost layer of the skin having a highly packed structure. When observed in longitudinal section, the stratum corneum appears as a wall composed of several columns of partially overlapped corneocytes (Fig. 1) . Each brick of this wall is made of 12-15 layers of corneocytes surrounded by a crystalline lipid matrix, organized in periodic lamellae. However, some defects in these junctions exist and, as a result of the imperfect overlapping of cell membranes, the whole structure could be considered as a poorly permeable nano-porous membrane (Cevc and Vierl, 2010 ) with a water content of about 10% (Fig. 2) . Considering the overall complexity of the skin, only few compounds having peculiar features can passively diffuse through this barrier. In general, such molecules have a low molecular weight (<500 Da), they do not have charge and they have a good hydrophilici-FRANCESCO CILURZO, SILVIA FRANZÉ, UMBERTO M. MUSAZZI ty/lipophilicity ratio . The passive diffusion of other compounds has to be enhanced by specialized techniques. Such approaches are based on the perturbation of the architecture of the stratum corneum that can be achieved by chemical or physical enhancement techniques (William and Barry, 2004; Swain et al., 2011) . The use of chemical skin penetration enhancers represents the long-standing approach for improving transdermal delivery of drugs. They are small molecules able to penetrate in the intercellular regions of the stratum corneum and increase the fluidity of the lipid components determining a temporary disruption of the skin barrier properties (William and Barry, 2004) . Alternatively, they may increase the drug solubility in the stratum corneum and, improving the drug thermodynamic activity, favour the passive diffusion process through the skin. Among the physical enhancement techniques, the iontophoresis and electroporation are the widely studied since the perturbation of the stratum corneum is reversible conversely to sonophoresis and the use of microneedles, which determine a disruption of its structure (Swain et al., 2011) .
Besides these well-established approaches, the possible use of nanovectors is also studied as demonstrated by the number of articles published in the last two decades which increased in an exponential fashion. 
NANOVECTORS AS (TRANS)DERMAL DELIVERY SYSTEMS
The nanovectors have been widely investigated to target a specific organ after parenteral administration and in this case the main issues in their clinical development are related to the uptake into the cells of the mononuclear phagocyte system and the difficulty to selectively target the pathological tissue. In the case of the cutaneous administration, these issues are further complicated by the stratum corneum properties that significantly limit the bioavailability of nanovectors (Fig. 2) . Thus, the use of nanotechnology should be thought mainly to target a drug in the deep layers of viable epidermis and/or dermis, rather than to obtain a systemic or regional pharmacological effect. Altogether, the nanosystems proposed for a cutaneous administration have been studied to reach one or more goals: -to favour the partition of a drug into the stratum corneum or viable epidermis; -to prevent the systemic absorption of the drug through the capillaries in the dermis; -to perform an occlusive function increasing the hydration of corneocytes and widening the hydrophilic pores (channel-like hydrophilic pathway, Fig. 2 ) within the lipids of stratum corneum; -to act as a local depot of the drug in the outer skin layers to delay the frequency of administration (this is desirable for drugs such as antibiotics, corticosteroids). Moreover, they could behave as skin penetration enhancers and, more in general, as controlled drug delivery systems.
The characteristics of the most frequently studied nanovectors are described in the following sections and their performances discussed on the basis of the considerations reported above.
Nanovesicles
The use of lipid to design nanovesicles is undoubtedly the most investigated approach over the past twenty years. The first efforts dealt with liposomes, which are made of lipid bilayers enclosing aqueous compartments (Fig. 3) . However, conventional liposomes are unable to penetrate the stratum corneum due to their stiffness. Nowadays, it is generally recognized that they can only enhance the drug retention into the skin disintegrating or fusing on the skin surface, thus exchanging lipid components with the stratum corneum and favouring the drug release (Cosco et al., 2008) . Hence, they can be advantageously used only to treat superficial skin diseases when a local depot is required. Thus, many formulative modifications of the basic composition of liposomes have been made to ameliorate their efficiency after application onto the skin.
Niosomes are self-assembled vesicles composed of non-ionic surfactants having a suitable packing parameter to form bilayers stabilized by cholesterol which lends, as in the case of phospholipids, to ordered structures and a modulation of the membrane's permeability (Khan et al., 2016, Fig. 3) . Since niosomes are characterized by a higher chemical stability with respect to liposomes, they have been proposed for a great variety of applications in the field of drug delivery, including their use for the cutaneous delivery of several active molecules (Abidin et al., 2016; Auda et al., 2016; Ghanbarzadeh et al., 2015; Gupta et al., 2016; Ioele et al., 2015; Lather et al., 2016; Moghddam et al., 2016; Pando et al., 2015; Zidan et al., 2016) .
The penetration mechanism in the case of niosomes is comparable to that described in case of conventional liposomes. First, they improve the thermodynamic activity of drugs acting as solubilizing agents; moreover, similarly to lipid vesicles, they partially loosen the lipid barrier of the stratum corneum fusing or aggregating on the skin surface (Ogiso et al., 1996) , thus behaving as skin penetration enhancers.
However, besides the existence of some scientific evidences on the efficacy of such systems (Manca et al., 2016) , huge doubts remain about their real penetration pattern after the cutaneous application and the real usefulness of these systems in cutaneous drug delivery.
Conversely, a further modification of the bilayer composition of liposomes led to the development of proper novel generations of lipid vesicles defined as "ultradeformable liposomes" and "ethosomes". The "ultradeformable" liposomes were described for the first time in 1992 by Cevc and co-workers and patented with the name of Transferosomes (IDEA AG) (Cevc et al., 1992) . In their basic structure, these systems are composed of phospholipids having fluid chains, and a single chain, nonionic surfactant, which destabilizes the bilayer allowing shape deformation at low energetic cost which permits the vesicles to pass through pores having a diameter up to one tenth of their radius (Romero et al., 2013, Fig. 3) . The force that drives the penetration of these vesicles seems to be the osmotic gradient. However, this potential mechanism of action is questioned since the water gradient would be abolished at the stratum corneum/epidermis interface and the hydrophilic pores are rare furrows. However, after dermal application of radioactive labelled transferosomes on a model animal, Cevc and Blume found moderate radioactivity levels in blood, whereas it was revealed in the liver suggesting the penetration of transferosomes as intact vesicles, since the organ cannot accumulate simple lipid molecules (Cevc and Blume, 1992) . The hypothesis of entire vesicles penetration is also supported by the efficiency of these carriers in enabling the skin delivery of macromolecules such as insulin (Cevc et al., 1996) , other large proteins for immunization (Paul A. et al., 1995) , low molecular weight heparins (Song et al., 2006; Song et al., 2011 ), siRNA (Geunsens et al., 2009 .
As a consequence of these promising data, a number of carriers are currently under clinical investigation for the treatment of several local pathologies. For a complete review see Romero and Morilla (2013) and Morilla and Romero (2016) .
Ethosomes are highly fluid vesicles derived from the combination of phospholipids and high ethanol content (20-45%), proposed for the first time by Touitou and co-workers in 2000 (Touitou et al., 2000, Fig. 3) . The presence of the alcoholic counterpart notably increases the permeability of the bilayer, which is less packed, and lends to the particles a negative zeta potential responsible of an increased colloidal stability (Morilla and Romero, 2016) . Since ethanol is also a well-known skin penetration enhancer, the increased penetration of such carriers through the skin barrier would be the result of a synergistic action of ethanol and lipid vesicles. In particular, ethanol is able to intercalate into the polar heads of the lipids of the stratum corneum loosening their tight organization and creating some gaps that would open the passage to the vesicles, which are fluids for the presence of ethanol itself (Touitou et al., 2000) . Following this pathway, ethosomes would enable the flux of the carried active molecules deeply into the skin, up to the dermis, where they can be absorbed to reach systemic effect. Then, compared to deformable liposomes, they are not the most suitable carriers when a local effect is desirable (Campani et al., 2016) .
Moreover, with respect to deformable liposomes, ethosomes can be applied under occlusive conditions and they can be formulated also as a transdermal patch (Romero et al., 2014) , which is the most accepted transdermal dosage form. Touitou and co-authors (2000) compared the performances of patches containing ethosomal testosterone with those of the commercial patch Testoderm ® . They found a 30-time increase of the in vitro permeated amount of testosterone through rabbit skin when it was delivered by ethosomal system in comparison to conventional patch.
The ethosomal patch also confirmed its higher efficacy in vivo, leading to higher blood level of testosterone after 5 days of application. Recently, glimepiride transdermal films loaded with a drug in ethosomal formulation were proposed as a valuable alternative to conventional oral tablets, since they showed a prolonged drug release with an in vitro good permeation profile of the active molecules. Moreover, the pharmacokinetic studies on human volunteers evidenced a decrease of the Cmax with respect to tablets, with following diminution of the side effects often associated to the oral administration of glimeripide .
A further improvement of ethosomes performances was obtained with the development of transethosomes, that, as suggested by their name, combine the deformability properties of transferosomes with the high fluidity of ethosomes, having in their composition both ethanol and an edge activator (e.g., a surfactant or a skin penetration enhancer) (Fig. 3) (Song et al., 2012) . However, also in this case, many efforts are required to better comprehend the real pathway of penetration of these vesicles and their efficacy on human skin in vivo.
Solid lipid nanoparticles
The solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) are spherical-like nanostructures characterized by a homogeneous inner structure of lipids that are solid at room temperature (Pardeike et al., 2009 ; Fig. 3 ). With respect to SLN which are composed only by a solid matrix, the lipidic phase of NLC can also contain lipids with lower melting points. SLN and NLC can be conveniently prepared using techniques (e.g., high pressure homogenization) that allow a fast production and an easy scale up, avoiding the use of organic solvents. In addition, small molecules, peptides and proteins can be homogenously dispersed in the SLN matrix (Almeida and Souto, 2007) . Considering these advantages, SLN were extensively studied as nanovectors for both pharmaceutical and cosmetic applications. In particular, SLN were proposed in cosmetic products for protecting active ingredients and increasing their penetration through the upper layers of human skin (Müller et al., 2002) . Indeed, Detoni and co-authors (2012) compared the performances of NLC loaded by resveratrol to those of liposomes and lipid-core nanocapsules in terms of chemical stability of the loaded drug and in vitro penetration profile through porcine skin. The results demonstrated that after exposure of UV-A radiation, NLC were more stable than liposomes protecting resveratrol from isomerization in the same extent that lipid-core nanocapsules. In addition, the permeation profile of resveratrol loaded in NLC was superimposable to that of the free-drug, when experiments were conducted in dark conditions; on the contrary an important improvement in the drug permeated amount was obtained when the dermis was exposed to UV-A radiation. However, these encouraging results of SLN or NLC were not due to the ability of the nanovector itself to penetrate through the skin. Since lipids used to design SLN or NLC generally melt at the skin temperature (i.e., 32°C), after cutaneous application both SLN and NCL melt on the skin surface, forming an adhesive layer with occlusive properties (Schäfer-Korting et al., 2007) . The consequent increase of the stratum corneum hydration, is the key factor to enhance the skin penetration of a drug (Wissing et al., 2001) .
Polymer-based nanovectors

Polymeric nanoparticles
Polymeric nanoparticles are nanostructures formed by a dense polymeric matrix, which ranges from 20 nm to about 500 nm (Fig. 3) . Their possible application to transdermal delivery was systematically studied by Alvarez-Román and co-authors (2004), using fluorescent polystyrene nanoparticles as model nanovector. The results evidenced that both 20-nm and 200-nm nanoparticles were not able to permeate significantly through the porcine skin, but 20-nm nanoparticles were highly distributed in follicular space. In agreement with these results, Vogt et al. demonstrated that only 40-nm polystyrene nanoparticles could distribute in hair follicles and permeated via their epithelium to distribute in the epidermal layer (Vogt et al., 2006) . Other authors suggested that polymeric nanoparticles could penetrate skin via follicular route when its barrier properties were altered. As an example, AbdelMottaleb et al. showed that ethyl cellulose nanoparticles (diameter <500 nm) significantly permeated through a mice skin model of dithranol-induced dermatitis inflammation (Abdel-Mottaleb et al., 2012a) . Again, Try et al. showed that the skin penetration of 70-nm PLGAnanoparticles was significantly increased both in murine and pig models of atopic dermatitis (Try et al., 2016) . In particular, the accumulation of nanoparticles were 15-fold and 3-fold higher in murine and pig inflamed skin, respectively, in comparison to corresponding healthy membranes.
Nanogels
Nanogels are a particular type of polymeric nanoparticles characterized by a loose inner structure, so that they can be imagined as nanosponges (Mavuso et al., 2015 ; Fig. 3) . Made of synthetic (e.g., PLGA, Eudragit ® RL 100) or natural polymers (e.g., chitosan, chitin, hyaluronic acid, gellan), they are obtained by chemically or physically crosslinking of polymeric chains in spherical-like networks (Di Meo et al., 2015) . This peculiar structure, along with the related physicochemical properties, permits designing nanogels with a high drug loading and able to be stimuli responsive (Chacko et al., 2012) , increasing the interest for their possible clinical applications.
In the field of transdermal drug delivery, they were recently proposed for the administration of both small molecules and proteins. Divya et al. prepared chitin nanogels loaded by two anti-psoriasis drugs, namely acitretin and aloe-emodin (Divya et al., 2016) . Although the dimension of these nanogels ranged from 100 to 250 nm, the in vitro permeation studies through pig ear skin showed that the retention and permeation profiles of drug-loaded nanogels were similar or higher than the control, a drug methanolic solution. Samah and Heard (2013) demonstrated that stimuli responsive nanogels, made of poly(N-isopropylacrylamide) and acrylic acid, were also able to improve the permeation profiles of small molecules (i.e., caffeine). Finally, Choi et al. (2012) demonstrated that Pluronic/chitosan nanogels were able to penetrate through the stratum corneum of human cadaver skin, improving the permeation profile of FITC-BSA.
As in the case of the previous nanovectors, the permeation mechanism of nanogel through animal and human skin models is far from being completely clarified. On the basis of the results obtained by polyglycerol-based nanogels, Rancan et al. (2016) suggested that their effectiveness to enhance the drug permeation could be related to their softness and their high stability due to the crosslinking. On the contrary, Smejkalova et al. (2017) showed that hyaluronan polymeric micelles, which have a nanogel-like structure, were able to permeate through pig ear skin, but they lost their structure in the deepest layers of the skin.
Metallic nanocarriers
Several inorganic nanosystems of various shape and materials, such as metals (e.g., gold, silver), metal oxide (e.g., iron oxide, zinc oxide, titanium dioxide), carbon or silica, were widely studied for dermatologic applications (Papakostas et al., 2011; Fig. 3) . Nevertheless, only nanomaterials made of zinc or titanium oxides are currently used in cosmetic products as physical sunscreen filters. Recently, the interest of scientific community for inorganic core nanoparticles (IONs) intended as drug-loaded nanovectors for treating cutaneous diseases has risen (Lee et al., 2015; Santini et al., 2015) . Constituted by an inorganic core, made of iron oxide or gold, coated by a polymer, such nanovectors combine the advantages given by the peculiar physicochemical properties of the inorganic core with the possibility to deliver active pharmacological moieties (e.g., small molecules, peptides, nucleic acids; Lee et al., 2015; Zheng et al., 2012) . In particular, ironoxide nanoparticles, which can be detect by MRI due to their superparamagnetic properties (Rockall et al., 2005) , could be proposed as theranostic agent for cutaneous or loco-regional diseases. According to literature, the skin permeation of inorganic nanovectors was significantly influenced by the core size, core shape and type of polymeric coating. Sonavane et al. (2008) demonstrated that both the permeation and the diffusion of gold nanoparticles through rat skin decreased significantly when the particle diameter moved from 15 to 105 nm.
The selection of a proper coating for IONs resulted also critical because of its impact on both the core stability in aqueous vehicle (Santini et al., 2015) and nanoparticles skin penetration (Baroli et al., 2007; Hsiao et al., 2016) . As an example, the permeation profile of gold nanoparticles (diameter measured by DLS: 20-40 nm) was significantly improved if they were coated by poly-(ethylene glycol) (Hsiao et al. 2016) . Similarly, the surface coating of IONs (diameter measured by TEM: <20nm) can alter their penetration profiles through full-thickness skin (Baroli et al. 2007) . Nevertheless, the capability of IONs to permeate the skin is far from being univocally proved. Indeed, although several studies have demonstrated the in vitro and in vivo permeation of such nanovectors in animal models, the scientific community is still discussing if such findings can be predictive of the IONs tendency to permeate the human skin (Monteiro-Riviere and Riviere, 2009).
CONCLUSIONS
Despite the possible advantages of nanovectors to improve the therapeutic performances of some active ingredients, the mechanism of penetration is not completely understood since contradictory results are available in literature. One of the reasons can be due to the species used in the skin penetration experiments and, in some cases, the experimental conditions. These differences are underlined by comparing the results obtained after exposing the skin of different mammalians to quantum dots (QD) that are nanoparticles in the 14-45 nm range characterized by an intense and photostable fluorescence (Monteiro-Riviere and Riviere, 2009). Indeed, QD were found in the liver of hairless mouse after their application on the intact skin suggesting that these nanoparticles could be minimally absorbed after transdermal administration (Tang et al., 2013; Gopee et al., 2009 ). In the case of rats, QD are able to reach dermis only depending on their morphology and surface characteristics (Zhang and Monteiro-Riviere, 2008; MonteiroRiviere and Riviere, 2009) and to penetrate in the porcine epidermis (Ryman-Rasmussen et al. 2006) and reach the stratum granulosum as in the case of fullerenes (Rouse, et al., 2007) , but remained confined on the stratum corneum surface when applied on the human skin (Gratieri et al., 2010) . Therefore, further investigations are required to better understand the possible mechanistic aspects involved in the penetration of these nanovectors rather than to obtain proofs of concept of their efficiency in different animal models, whether the human skin cannot be used as skin model in in vitro permeation studies.
In conclusion, although the great number of attempts made on this field, up to now we are still far from the development of cutaneous dosage forms containing nanovectors able to deeply penetrate the skin barrier for treating effectively severe diseases. Indeed, the only drug products appeared on the European market are based on lipid vesicles, namely a conventional liposome intended for the localization in the stratum corneum of econazole, an antimycotic drug, and a transethosome designed to enhance the skin penetration of diclofenac.
